Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
$1.26
-3.1%
$1.19
$0.93
$3.42
$62.94M1.35385,582 shs106,893 shs
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
$3.20
-3.6%
$3.83
$2.68
$45.53
$10.75M2.28108,615 shs78,517 shs
Cue Health Inc. stock logo
HLTH
Cue Health
$0.04
-29.8%
$0.07
$0.04
$0.74
$6.91M1.0913.38 million shs96.00 million shs
Seer, Inc. stock logo
SEER
Seer
$2.01
+1.5%
$2.03
$1.56
$2.63
$118.33M1.54326,575 shs336,523 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
0.00%+2.44%0.00%-24.55%-46.61%
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
0.00%-12.33%-13.98%-3.03%-92.89%
Cue Health Inc. stock logo
HLTH
Cue Health
0.00%0.00%0.00%0.00%0.00%
Seer, Inc. stock logo
SEER
Seer
0.00%-2.90%-4.29%+8.06%+18.24%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
1.0972 of 5 stars
3.01.00.00.00.01.70.6
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
0.8665 of 5 stars
3.11.00.00.00.00.00.6
Cue Health Inc. stock logo
HLTH
Cue Health
N/AN/AN/AN/AN/AN/AN/AN/A
Seer, Inc. stock logo
SEER
Seer
2.5563 of 5 stars
3.03.00.00.01.83.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
2.00
Hold$2.5198.89% Upside
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
2.25
Hold$7.00118.75% Upside
Cue Health Inc. stock logo
HLTH
Cue Health
0.00
N/AN/AN/A
Seer, Inc. stock logo
SEER
Seer
2.00
Hold$3.0049.25% Upside

Current Analyst Ratings Breakdown

Latest BNGO, AKYA, SEER, and HLTH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2025
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$1.80 ➝ $1.08
4/29/2025
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$3.50 ➝ $1.80
4/14/2025
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$2.40 ➝ $1.65
4/9/2025
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$10.00
4/2/2025
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$1.00 ➝ $4.00
3/25/2025
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Equal Weight$3.50 ➝ $1.80
(Data available from 6/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
$81.67M0.77N/AN/A$0.15 per share8.40
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
$30.78M0.35N/AN/A$18.12 per share0.18
Cue Health Inc. stock logo
HLTH
Cue Health
$70.94M0.10N/AN/A$1.62 per share0.03
Seer, Inc. stock logo
SEER
Seer
$14.17M8.35N/AN/A$5.54 per share0.36
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
-$55.37M-$0.97N/AN/AN/A-59.44%-487.85%-35.86%8/4/2025 (Estimated)
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
-$112.02M-$138.92N/AN/A-294.05%-125.75%-71.96%8/6/2025 (Estimated)
Cue Health Inc. stock logo
HLTH
Cue Health
-$373.46M-$2.44N/AN/AN/A-526.48%-67.82%-53.79%N/A
Seer, Inc. stock logo
SEER
Seer
-$86.60M-$1.41N/AN/AN/A-560.90%-24.69%-22.13%8/6/2025 (Estimated)

Latest BNGO, AKYA, SEER, and HLTH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2025Q1 2025
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
-$3.49-$1.15+$2.34-$1.15$6.25 million$6.46 million
5/13/2025Q1 2025
Seer, Inc. stock logo
SEER
Seer
-$0.37-$0.34+$0.03-$0.34$3.25 million$4.21 million
5/12/2025Q1 2025
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
-$0.29-$0.32-$0.03-$0.32$20.19 million$16.64 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
N/AN/AN/AN/AN/A
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
N/AN/AN/AN/AN/A
Cue Health Inc. stock logo
HLTH
Cue Health
N/AN/AN/AN/AN/A
Seer, Inc. stock logo
SEER
Seer
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
10.12
0.61
0.40
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
0.07
1.70
1.34
Cue Health Inc. stock logo
HLTH
Cue Health
N/A
2.54
2.22
Seer, Inc. stock logo
SEER
Seer
N/A
19.34
18.81

Institutional Ownership

CompanyInstitutional Ownership
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
79.42%
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
11.35%
Cue Health Inc. stock logo
HLTH
Cue Health
45.49%
Seer, Inc. stock logo
SEER
Seer
75.20%

Insider Ownership

CompanyInsider Ownership
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
7.30%
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
0.90%
Cue Health Inc. stock logo
HLTH
Cue Health
12.50%
Seer, Inc. stock logo
SEER
Seer
11.28%
CompanyEmployeesShares OutstandingFree FloatOptionable
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
9049.95 million46.31 millionOptionable
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
3003.36 million3.33 millionOptionable
Cue Health Inc. stock logo
HLTH
Cue Health
726159.09 million139.21 millionOptionable
Seer, Inc. stock logo
SEER
Seer
16058.87 million52.23 millionOptionable

Recent News About These Companies

Panchamasali fight for 2A reservation will resume: Seer
Panchamasali agitation will resume: seer
In the seer’s stillness – A journey through Yogic discipline
Yalburga seer’s yoga routine benefits devotees
Baba Vanga's chilling WW3 prediction

New MarketBeat Followers Over Time

Media Sentiment Over Time

Akoya Biosciences stock logo

Akoya Biosciences NASDAQ:AKYA

$1.26 -0.04 (-3.08%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$1.26 +0.00 (+0.40%)
As of 06/20/2025 05:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. It has a collaboration agreement with NeraCare that enables personalized therapy selection for early-stage melanoma patients. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

Bionano Genomics stock logo

Bionano Genomics NASDAQ:BNGO

$3.20 -0.12 (-3.61%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$3.29 +0.09 (+2.81%)
As of 06/20/2025 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. The company also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.

Cue Health stock logo

Cue Health NASDAQ:HLTH

Cue Health Inc. operates as a healthcare technology company. It provides the Cue Health platform that offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, as well as on-demand telehealth consultations and treatment options for a range of health and wellness needs. It offers Cue Integrated Care platform comprising hardware, software, and diagnostic components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, including integration with electronic medical record system, pharmacies and last-mile delivery, clinician networks, and laboratories. The company also provides COVID-19 testing kits. The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.

Seer stock logo

Seer NASDAQ:SEER

$2.01 +0.03 (+1.52%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$2.00 0.00 (-0.25%)
As of 06/20/2025 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.